What is the nice criteria for Mounjaro?
•
3 min read
In December 2024, the National Institute for Health and Care Excellence (NICE) officially recommended tirzepatide (Mounjaro) for managing overweight and obesity within the NHS, marking a significant step for patients in England. However, access is determined by strict, phased eligibility criteria, making it essential to understand the specific NICE criteria for Mounjaro to determine who qualifies.
